| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.36 | 2e-11 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.29 | 9e-11 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.33 | 4e-09 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.25 | 3e-08 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.2 | 5e-07 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.19 | 9e-06 |